ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Brexpiprazole in Treatment of Children and Adolescents With Irritability Associated With Autism Spectrum Disorder for Subjects That Have Completed Participation in 331-201-00148

ClinicalTrials.gov ID: NCT04258839

Public ClinicalTrials.gov record NCT04258839. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 16, 2026, 11:24 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multicenter, Open Label Trial to Evaluate the Long-term Safety and Tolerability of Brexpiprazole in Treatment of Children and Adolescents With Irritability Associated With Autism Spectrum Disorder

Study identification

NCT ID
NCT04258839
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Industry
Enrollment
95 participants

Conditions and interventions

Interventions

  • Brexpiprazole Drug

Drug

Eligibility (public fields only)

Age range
5 Years to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 22, 2020
Primary completion
Mar 15, 2023
Completion
Mar 15, 2023
Last update posted
May 29, 2024

2020 – 2023

United States locations

U.S. sites
28
U.S. states
19
U.S. cities
27
Facility City State ZIP Site status
Dothan Behavioral Medicine Clinic Dothan Alabama 36303
Southwest Autism Research and Resource Center Phoenix Arizona 85006
University of California San Francisco, Nancy Friend Pritzker Psychiatry San Francisco California 94143-3132
APG Research Orlando Florida 32803
Autism Assessment, Research, Treatment and Services (AARTS) center Chicago Illinois 60612
Research site Lake Charles Louisiana 70629
The Lurie Center for Autism Lexington Massachusetts 02421-3114
Research site Bloomfield Hills Michigan 48302
Thompson Center for Autism and Neurodevelopment Columbia Missouri 65211
Research site Saint Charles Missouri 63304
Alivation Lincoln Nebraska 68526
Center for Psychiatry and Behavioral Medicine Inc. Las Vegas Nevada 89128
Rutger's-New Jersey Medical Scholl Clinical Research Unit Newark New Jersey 07103
For additional information regarding sites Princeton New Jersey 08540
Bioscience Research Mount Kisco New York 10549
Research site New York New York 10036
Finger Lakes Clinical Research Rochester New York 14618
Richmond Behavioral Associates Staten Island New York 10314
Research Site Avon Lake Ohio 44012
The Holloway Group, Inc Oklahoma City Oklahoma 73116
Access Clinical Trials Nashville Tennessee 37203
Research site Austin Texas 78759
Cedar Health Research Dallas Texas 75251
Research site San Antonio Texas 78249
UT Health San Antonio Long School of Medicine, Department of Psychiatry and Behavioral Sciences San Antonio Texas 78289
Family Psychiatry of the Woodlands The Woodlands Texas 77381
Woodstock Research Center Woodstock Vermont 05091
Core Clinical Research Everett Washington 98201

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04258839, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 29, 2024 · Synced May 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04258839 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →